Longeveron Inc. 8-K

What Happened Longeveron Inc. announced that on March 24, 2026 Nasdaq granted the company an additional 180-day period, until September 21, 2026, to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The Company originally received a notice of non-compliance on September 22, 2025 and was given until March 23, 2026; the March 24 notice extends that cure period. The Company’s listing remains fully effective and there is no immediate delisting.

Key Details

• Nasdaq first notified Longeveron of non-compliance on September 22, 2025 after 30 consecutive business days with a closing bid below $1.00.
• Initial cure period: 180 days (until March 23, 2026); Nasdaq granted an additional 180 days on March 24, 2026 (new deadline September 21, 2026).
• To regain compliance, the closing bid must be at least $1.00 for a minimum of 10 consecutive business days (subject to Nasdaq discretion).
• The Company said it may consider options such as a reverse stock split to regain compliance; there is no assurance it will succeed.

Why It Matters This affects investors because continued failure to meet Nasdaq’s minimum bid standard can lead to delisting, which typically reduces liquidity and can limit investor access and shareholder value. An extended cure period gives the company more time to restore its share price or take corporate actions (e.g., reverse split) that change share count and per-share metrics. Investors should monitor the company’s stock price, any shareholder votes or proposals related to a reverse split, and future SEC filings for updates.